Overexpression of S100P promotes colorectal cancer metastasis and decreases chemosensitivity to 5-FU in vitro

Molecular and Cellular Biochemistry

Volumn 389, Issue 1-2, 2014, Pages 257-264

  Dong, Lei ^a   Wang, Fule ^a   Yin, Xiaona ^b   Chen, Ling ^c   Li, Gang ^a   Lin, Feiyan ^a   Ni, Wuhua ^a   Wu, Jianbo ^a   Jin, Rong ^a   Jiang, Lei ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Clinical Laboratory   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Chemosensitivity; Colorectal cancer; Metastasis; S100P

Indexed keywords

FLUOROURACIL; MEMBRANE PROTEIN; S100P PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL MIGRATION; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896548604     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1947-5     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96. doi:10.3322/CA.2007.0010 (Pubitemid 351521864)
2. Lockhart-Mummery HE, Ritchie JK, Hawley PR (1976) The results of surgical treatment for carcinoma of the rectum of St Mark's Hospital from 1948 to 1972. Br J Surg 63(9):673-677
3. Khair G, Monson JR, Greenman J (2007) Epithelial molecular markers in the peripheral blood of patients with colorectal cancer. Dis Colon Rectum 50(8):1188-1203. doi:10.1007/s10350-006-0875-9 (Pubitemid 47087460)
4. Russell AH, Pelton J, Reheis CE, Wisbeck WM, Tong DY, Dawson LE (1985) Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategies. Cancer 56(6):1446-1451 (Pubitemid 15230595)
5. Jiang H, Hu H, Tong X, Jiang Q, Zhu H, Zhang S (2012) Calcium-binding protein S100P and cancer: mechanisms and clinical relevance. J Cancer Res Clin Oncol 138(1):1-9. doi:10.1007/s00432-011-1062-5
6. Tothova V, Gibadulinova A (2013) S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer. Acta Virol 57(2):238-246
7. Wang G, Platt-Higgins A, Carroll J, de Silva Rudland S, Winstanley J, Barraclough R, Rudland PS (2006) Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66(2):1199-1207. doi:10.1158/0008-5472.CAN-05-2605 (Pubitemid 43165991)
8. Fuentes MK, Nigavekar SS, Arumugam T, Logsdon CD, Schmidt AM, Park JC, Huang EH (2007) RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 50(8):1230-1240. doi:10.1007/s10350-006-0850-5 (Pubitemid 47087458)
9. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, Hansen M, Eloranta JJ, Bhakta V, Brentnall TA, Luttges J, Kloppel G, Lemoine NR (2005) Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 166(1):81-92. doi:10.1016/S0002-9440(10)62234-1 (Pubitemid 40051662)
10. Barry S, Chelala C, Lines K, Sunamura M, Wang A, Marelli-Berg FM, Brennan C, Lemoine NR, Crnogorac-Jurcevic T (2013) S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells. Clin Exp Metastasis 30(3):251-264. doi:10.1007/s10585-012-9532-y
11. Chandramouli A, Mercado-Pimentel ME, Hutchinson A, Gibadulinova A, Olson ER, Dickinson S, Shanas R, Davenport J, Owens J, Bhattacharyya AK, Regan JW, Pastorekova S, Arumugam T, Logsdon CD, Nelson MA (2010) The induction of S100P expression by the Prostaglandin E(2) (PGE(2))/EP4 receptor signaling pathway in colon cancer cells. Cancer Biol Ther 10(10):1056-1066. doi:10.4161/cbt.10.10. 13373
12. Jiang L, Lai YK, Zhang J, Wang H, Lin MC, He ML, Kung HF (2011) Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis. Mol Med 17(7-8):709-716. doi:10.2119/molmed.2011.00008
13. McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ (2011) The role of S100 genes in breast cancer progression. Tumour Biol 32(3):441-450. doi:10.1007/s13277-010-0137-2
14. Arumugam T, Logsdon CD (2011) S100P: a novel therapeutic target for cancer. Amino Acids 41(4):893-899. doi:10.1007/s00726-010-0496-4
15. Inti Zlobec RS, Terracciano Luigi, Jeremy R, Jass Alessandro Lugli (2007) Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 60:1112-1116
16. Jiang L, Lai YK, Zhang JF, Chan CY, Lu G, Lin MC, He ML, Li JC, Kung HF (2012) Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-beta-susceptible hepatocellular carcinoma cells. World J Gastroenterol 18(17):2035-2042. doi:10.3748/wjg.v18.i17.2035
17. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T (2007) The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 67(18):8633-8642. doi:10.1158/0008-5472.CAN-07-0545 (Pubitemid 47437439)
18. Wang Q, Zhang YN, Lin GL, Qiu HZ, Wu B, Wu HY, Zhao Y, Chen YJ, Lu CM (2012) S100P, a potential novel prognostic marker in colorectal cancer. Oncol Rep 28(1):303-310. doi:10.3892/or.2012.1794
19. Arumugam T, Simeone DM, Van Golen K, Logsdon CD (2005) S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11(15):5356-5364. doi:10.1158/1078-0432.CCR-05-0092 (Pubitemid 41060808)
20. Arumugam T, Ramachandran V, Logsdon CD (2006) Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 98(24):1806-1818. doi:10.1093/jnci/djj498 (Pubitemid 46017932)
21. Bartling B, Rehbein G, Schmitt WD, Hofmann HS, Silber RE, Simm A (2007) S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy. Eur J Cancer 43(13):1935-1943. doi:10.1016/j.ejca.2007.06.010 (Pubitemid 47284868)
22. Parkkila S, Pan PW, Ward A, Gibadulinova A, Oveckova I, Pastorekova S, Pastorek J, Martinez AR, Helin HO, Isola J (2008) The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol 8:2. doi:10.1186/1472-6890-8-2
23. + binding properties. Eur J Biochem 207(2):541-547
24. Sato N, Hitomi J (2002) S100P expression in human esophageal epithelial cells: human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation. Anat Rec 267(1):60-69. doi:10.1002/ar.10085 (Pubitemid 34465299)
25. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA, Orntoft TF (2005) Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54(3):374-384. doi:10.1136/gut.2003.036848 (Pubitemid 40299094)
26. Averboukh L, Liang P, Kantoff PW, Pardee AB (1996) Regulation of S100P expression by androgen. Prostate 29(6):350-355. doi:10.1002/(SICI)1097- 0045(199612)29:6〈350::AID-PROS2〉3.0.CO;2-C (Pubitemid 27014349)
27. Onyeagucha BC, Mercado-Pimentel ME, Hutchison J, Flemington EK, Nelson MA (2013) S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Exp Cell Res 319(13):2081-2090. doi:10.1016/j.yexcr. 2013.05.009
28. Emberley ED, Murphy LC, Watson PH (2004) S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 82(4):508-515. doi:10.1139/o04-052 (Pubitemid 39286966)
29. Ge F, Wang C, Wang W, Wu B (2013) S100P predicts prognosis and drug resistance in gastric cancer. Int J Biol Markers. doi:10.5301/jbm.5000034
30. Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3(5):330-338. doi:10.1038/nrc1074 (Pubitemid 37328853)
31. Akao Y, Noguchi S, Iio A, Kojima K, Takagi T, Naoe T (2011) Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 300(2):197-204. doi:10.1016/j.canlet.2010.10.006